"Study to Evaluate the Epidemiology and the Characteristics Omics in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain"

CompletedOBSERVATIONAL
Enrollment

376

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Inflammatory Bowel Diseases
Trial Locations (16)

13005

Hospital Universitario de Ciudad Real, Ciudad Real

14004

Hospital Universitario Reina Sofia, Córdoba

15706

Hospital Universitario Santiago de Compostela, Santiago de Compostela

22004

Hospital San Jorge, Huesca

28006

Hospital Universitario de La Princesa, Madrid

28942

Hospital Universitario de Fuenlabrada, Fuenlabrada

30008

Hospital Universitario Morale Mesenguer, Murcia

33011

Hospital Universitario Central de Asturias, Oviedo

35020

Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria

39008

Hospital Universitaro Marqués de Valdecilla, Santander

46026

Hospital Universitario y Politécnico La Fe, Valencia

47005

Hospital Clínico Univesitario de Valladolid, Valladolid

48960

Hospital de Galdakao, Galdakao

08221

Hospital Universitario Mutua Terrasa, Terrassa

03010

Hospital General universitario de Alicante, Alicante

07010

Hospital Universitario Son Espases, Palma de Mallorca

All Listed Sponsors
lead

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

NCT03689257 - "Study to Evaluate the Epidemiology and the Characteristics Omics in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain" | Biotech Hunter | Biotech Hunter